propofol-aminoacid derivative (Lipicard)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepropofol-aminoacid derivative (Lipicard)
Drug Alias NameGabafol
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonistsSodium channels blockers
TargetsSodium channelsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAnesthesia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLipicard Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLipicard Technologies
Active IndicationsN/A
Inactive IndicationsAnesthesia

Other Information

ATC CodeN/A
Related LinksN/A